Search

Search results

88 results found

A Novel Multi-organ Male Model of Alcohol-induced Acute-on-chronic Liver Failure Reveals NET-mediated Hepatocellular Death, Which is Prevented by RIPK3 Inhibition.

Ortega-Ribera, Martí, Yuan Zhuang, Mrigya Babuta, Veronika Brezani, Radhika S Joshi, Zsuzsanna Zsengeller, Prashanth Thevkar Nagesh, Yanbo Wang, Roderick Bronson, and Gyongyi Szabo. 2025. “A Novel Multi-Organ Male Model of Alcohol-Induced Acute-on-Chronic Liver Failure Reveals NET-Mediated Hepatocellular Death, Which Is Prevented by RIPK3 Inhibition.”. Cellular and Molecular Gastroenterology and Hepatology 19 (4): 101446.

Introducing the 2019 American Association for the Study of Liver Diseases Guidance on Alcohol-Associated Liver Disease.

Lucey, Michael Ronan, Gene Y Im, Jessica L Mellinger, Gyongyi Szabo, and David W Crabb. 2020. “Introducing the 2019 American Association for the Study of Liver Diseases Guidance on Alcohol-Associated Liver Disease.”. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 26 (1): 14-16.

Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis.

Dasarathy, Srinivasan, Mack C Mitchell, Bruce Barton, Craig J McClain, Gyongyi Szabo, Laura E Nagy, Svetlana Radaeva, and Arthur J McCullough. 2020. “Design and Rationale of a Multicenter Defeat Alcoholic Steatohepatitis Trial: (DASH) Randomized Clinical Trial to Treat Alcohol-Associated Hepatitis.”. Contemporary Clinical Trials 96: 106094.